ABVX
Price
$7.40
Change
+$0.22 (+3.06%)
Updated
Jun 27 closing price
Capitalization
447.04M
44 days until earnings call
CGON
Price
$25.95
Change
-$0.12 (-0.46%)
Updated
Jun 27 closing price
Capitalization
1.98B
40 days until earnings call
Interact to see
Advertisement

ABVX vs CGON

Header iconABVX vs CGON Comparison
Open Charts ABVX vs CGONBanner chart's image
Abivax SA
Price$7.40
Change+$0.22 (+3.06%)
Volume$241.78K
Capitalization447.04M
CG Oncology
Price$25.95
Change-$0.12 (-0.46%)
Volume$1.28M
Capitalization1.98B
ABVX vs CGON Comparison Chart in %
Loading...
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABVX vs. CGON commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABVX is a Buy and CGON is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (ABVX: $7.40 vs. CGON: $25.95)
Brand notoriety: ABVX and CGON are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABVX: 118% vs. CGON: 94%
Market capitalization -- ABVX: $447.04M vs. CGON: $1.98B
ABVX [@Biotechnology] is valued at $447.04M. CGON’s [@Biotechnology] market capitalization is $1.98B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABVX’s FA Score shows that 0 FA rating(s) are green whileCGON’s FA Score has 0 green FA rating(s).

  • ABVX’s FA Score: 0 green, 5 red.
  • CGON’s FA Score: 0 green, 5 red.
According to our system of comparison, ABVX is a better buy in the long-term than CGON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABVX’s TA Score shows that 4 TA indicator(s) are bullish while CGON’s TA Score has 2 bullish TA indicator(s).

  • ABVX’s TA Score: 4 bullish, 6 bearish.
  • CGON’s TA Score: 2 bullish, 3 bearish.
According to our system of comparison, CGON is a better buy in the short-term than ABVX.

Price Growth

ABVX (@Biotechnology) experienced а +23.95% price change this week, while CGON (@Biotechnology) price change was +1.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

ABVX is expected to report earnings on Aug 11, 2025.

CGON is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGON($1.98B) has a higher market cap than ABVX($447M). ABVX YTD gains are higher at: 1.093 vs. CGON (-9.519). CGON has higher annual earnings (EBITDA): -134.35M vs. ABVX (-170.04M). CGON has more cash in the bank: 688M vs. ABVX (104M). CGON has less debt than ABVX: CGON (1.04M) vs ABVX (92.6M). CGON has higher revenues than ABVX: CGON (662K) vs ABVX (0).
ABVXCGONABVX / CGON
Capitalization447M1.98B23%
EBITDA-170.04M-134.35M127%
Gain YTD1.093-9.519-11%
P/E RatioN/AN/A-
Revenue0662K-
Total Cash104M688M15%
Total Debt92.6M1.04M8,938%
TECHNICAL ANALYSIS
Technical Analysis
ABVXCGON
RSI
ODDS (%)
Bearish Trend 2 days ago
75%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 3 days ago
75%
Declines
ODDS (%)
Bearish Trend 9 days ago
87%
Bearish Trend 13 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
75%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ABVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CCQYX15.230.09
+0.59%
Columbia Disciplined Core Inst3
WILCX10.460.03
+0.29%
Wasatch Global Value Institutional
DNLYX59.240.13
+0.22%
BNY Mellon Active MidCap Y
SMFPX10.52N/A
N/A
Westwood Salient MLP & Engy Infras C
IAFEX13.79N/A
N/A
FI Instl Grp All Frgn Eq Env & Scl Val

ABVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABVX has been loosely correlated with SYRE. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ABVX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABVX
1D Price
Change %
ABVX100%
+3.06%
SYRE - ABVX
38%
Loosely correlated
-4.99%
XENE - ABVX
38%
Loosely correlated
+0.62%
CGON - ABVX
37%
Loosely correlated
-0.46%
MLTX - ABVX
35%
Loosely correlated
+0.32%
DNLI - ABVX
35%
Loosely correlated
-2.69%
More

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with IDYA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
-0.46%
IDYA - CGON
60%
Loosely correlated
-4.13%
SYRE - CGON
57%
Loosely correlated
-4.99%
ACLX - CGON
57%
Loosely correlated
+0.90%
NUVL - CGON
56%
Loosely correlated
+0.70%
KYMR - CGON
54%
Loosely correlated
-3.48%
More